tiprankstipranks
Advertisement
Advertisement
LongBio Pharma Fully Exercises Over-Allotment Option to Raise HK$194.3 Million
PremiumCompany AnnouncementsLongBio Pharma Fully Exercises Over-Allotment Option to Raise HK$194.3 Million
2M ago
LongBio Pharma’s LP-003 Hits Phase III Goals in Seasonal Allergic Rhinitis
Premium
Company Announcements
LongBio Pharma’s LP-003 Hits Phase III Goals in Seasonal Allergic Rhinitis
2M ago
LongBio Pharma Sets 2025 AGM to Decide Profit Distribution and Capital Mandates
Premium
Company Announcements
LongBio Pharma Sets 2025 AGM to Decide Profit Distribution and Capital Mandates
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100